Agarwalla Capital

#ResearchReport - BULLS & BEARS (June 2022): Market slumps for the second consecutive month. Read more: http://ow.ly/bUzh50Jt9baDisclaimer: http://ow.ly/9qw050Jt9bb #ResearchReport

#ResearchReport Eris Lifesciences Ltd.: Niche launches to aid growth over the medium term. 📑📊 Read more at: http://ow.ly/kx0p50JbKcT Disclaimer: http://ow.ly/puzQ50JbKcU #ResearchReport

#ResearchReport - BULLS & BEARS (May 2022): FY23 begins on a cautious note; FIIs saw outflows for the seventh straight month. Read more: http://ow.ly/ObBQ50IYK7T 📊📈 Disclaimer: http://ow.ly/1Zif50IYK7Q #ResearchReport

#ResearchReport Ashok Leyland - Revival in cycle and market share to drive strong growth. Read more at: http://ow.ly/yrvI50IU4lC 📑📊 Disclaimer: http://ow.ly/JVb650IU4lz #ResearchReport

#ResearchReport KNR Constructions Ltd - Superior execution with a comfortable Balance Sheet. Read more at: http://ow.ly/nsuo50IT32K 📑📊 Disclaimer: http://ow.ly/jRas50IT32J #ResearchReport

#ResearchReport Galaxy Surfactants - EFatty Alcohol price on the boil, may scald margins! Read more at: http://ow.ly/6fRn50IQVbI 📑📊 Disclaimer: http://ow.ly/z9ph50IQVbF #ResearchReport

#ResearchReport India Strategy - Earnings growth in FY22 at the highest since FY04; margin headwinds persists. Read more at: http://ow.ly/vjgs50IPpsw 📑📊 Disclaimer: http://ow.ly/GihE50IPpst #ResearchReport

#ResearchReport Gland Pharma Ltd. - Well-placed to gain from the drug shortages in the US. Read more at: http://ow.ly/UPJt50IPoLB 📑📊 Disclaimer: http://ow.ly/oubm50IPoLA #ResearchReport

#ResearchReport Trent Ltd. - Continues to grow at an accelerate pace. Read more at: http://ow.ly/OGOs50IOgS3 📑📊 Disclaimer: http://ow.ly/M8kF50IOgS5 #ResearchReport